{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:18:05Z","timestamp":1785860285848,"version":"3.56.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1097\/01.mbc.0000220247.97164.ea","type":"journal-article","created":{"date-parts":[[2006,3,29]],"date-time":"2006-03-29T04:02:07Z","timestamp":1143604927000},"page":"221-224","source":"Crossref","is-referenced-by-count":6,"title":["Influence of warfarin therapy on activated factor VII clotting activity"],"prefix":"10.1097","volume":"17","author":[{"given":"Giuseppe","family":"Lippi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Montagnana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luca","family":"Salvagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Cesare","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210203","doi-asserted-by":"crossref","first-page":"xi","DOI":"10.1016\/j.hoc.2004.09.009","article-title":"Antithrombotic therapy: current practice and future trends","volume":"19","author":"Bick","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"issue":"Suppl","key":"R2-10-20210203","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1378\/chest.119.1_suppl.8S","article-title":"Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"R3-10-20210203","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/bmj.325.7367.762","article-title":"ABC of antithrombotic therapy: an overview of antithrombotic therapy","volume":"325","author":"Blann","year":"2002","journal-title":"BMJ"},{"issue":"Suppl B","key":"R4-10-20210203","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ehjsup.2004.01.012","article-title":"The re-emergence of anticoagulation in coronary disease","volume":"6","author":"Antman","year":"2004","journal-title":"Eur Heart J"},{"key":"R5-10-20210203","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1055\/s-0037-1615385","article-title":"Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?","volume":"80","author":"Barcellona","year":"1998","journal-title":"Thromb Haemost"},{"key":"R6-10-20210203","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1182\/blood.V81.3.734.734","article-title":"Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation","volume":"81","author":"Morrissey","year":"1993","journal-title":"Blood"},{"key":"R7-10-20210203","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.ATV.15.2.241","article-title":"Suppression of plasma-activated factor VII levels by warfarin therapy","volume":"15","author":"Sakata","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R8-10-20210203","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood.V85.11.3034.bloodjournal85113034","article-title":"Effect of treatment with low-dose warfarin-aspirin on activated factor VII","volume":"85","author":"Raskob","year":"1995","journal-title":"Blood"},{"key":"R9-10-20210203","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00001721-199611000-00009","article-title":"Plasma levels of activated FVII in various diseases","volume":"7","author":"Yamada","year":"1996","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R10-10-20210203","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-0038-1650364","article-title":"Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease","volume":"75","author":"Miller","year":"1996","journal-title":"Thromb Haemost"},{"key":"R11-10-20210203","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-0037-1615678","article-title":"Un update of the Gr\u00fctzbalg hypothesis: the role of thrombosis and coagulation in atherosclerotic progression","volume":"85","author":"Yee","year":"2001","journal-title":"Thromb Haemost"},{"key":"R12-10-20210203","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1055\/s-0037-1616734","article-title":"The pleiotropic effects of tissue factor: a possible role for factor VIIa-induced intracellular signalling?","volume":"86","author":"Versteeg","year":"2001","journal-title":"Thromb Haemost"},{"key":"R13-10-20210203","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1055\/s-0037-1616129","article-title":"The TF:VIIa complex: clinical significance, structure\u2013function relationships and its role in signaling and metastasis","volume":"86","author":"Konigsberg","year":"2001","journal-title":"Thromb Haemost"},{"key":"R14-10-20210203","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00005344-200405000-00009","article-title":"Tissue factor coagulation pathway: a new therapeutic target in atherothrombosis","volume":"43","author":"Viles-Gonzalez","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"R15-10-20210203","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0037-1963(01)90140-4","article-title":"The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis","volume":"38","author":"Hoffman","year":"2001","journal-title":"Semin Hematol"},{"key":"R16-10-20210203","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1073\/pnas.86.8.2839","article-title":"Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque","volume":"86","author":"Wilcox","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"R17-10-20210203","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1172\/JCI110945","article-title":"Cultured human endothelial cells generate tissue factor in response to endotoxin","volume":"71","author":"Colucci","year":"1983","journal-title":"J Clin Invest"},{"key":"R18-10-20210203","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-2003-40678","article-title":"Erhardtsen E. rFVIIai in acute coronary syndromes","volume":"3","author":"Sorensen","year":"2003","journal-title":"Semin Vasc Med"},{"key":"R19-10-20210203","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1161\/01.ATV.17.8.1539","article-title":"Coagulation factor VII and the risk of coronary heart disease in healthy men","volume":"17","author":"Junker","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R20-10-20210203","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.CIR.101.4.372","article-title":"Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes","volume":"101","author":"Colucci","year":"2000","journal-title":"Circulation"},{"key":"R21-10-20210203","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1056\/NEJM200009143431104","article-title":"Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease","volume":"343","author":"Girelli","year":"2000","journal-title":"N Engl J Med"},{"key":"R22-10-20210203","first-page":"E12","article-title":"Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer","volume":"86","author":"Franchini","year":"2001","journal-title":"Haematologica"},{"key":"R23-10-20210203","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-2000-8464","article-title":"Recombinant FVIIa in the treatment of warfarin bleeding","volume":"26","author":"Berntorp","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"R24-10-20210203","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-137-11-200212030-00009","article-title":"Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate","volume":"137","author":"Deveras","year":"2002","journal-title":"Ann Intern Med"},{"key":"R25-10-20210203","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-139-9-200311040-00020","article-title":"Laboratory monitoring of high-dose factor VIIa therapy [letter]","volume":"139","author":"Hoffman","year":"2003","journal-title":"Ann Intern Med"},{"key":"R26-10-20210203","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2516.2001.00478.x","article-title":"A comparison of FVII:C and FVIIa assays for the monitoring of recombinant factor VIIa treatment","volume":"7","author":"Cid","year":"2001","journal-title":"Haemophilia"},{"key":"R27-10-20210203","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00001721-200307000-00013","article-title":"Standardization of factor VII\/activated factor VII measurement in plasma of patients treated with recombinant factor activated VII","volume":"14","author":"Goudemand","year":"2003","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-200604000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:22:17Z","timestamp":1785856937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200604000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mbc.0000220247.97164.ea","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}